ArticleNucleic acids research2026
U2AF2 controls alternative splicing in speckle-proximal regions in an RS domain-dependent manner.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Splicing factor U2AF2 is known to play a pivotal role for 3' splice site recognition at an early step of spliceosome assembly. Here, using proximity labeling and biochemical confirmations, we extend the repertoire of putative functional partners of U2AF2 mainly for splicing, chromatin modification, transcription, 3' end processing, and RNA methylation. Removal of the U2AF2 RS domain alters numerous interactions, including self-association, reduces its localization to nuclear speckles, and impacts splicing genome-wide in a manner that depends both on splicing signals and on intron length. Indeed, cassette exon flanked by short introns in genes or transcripts located close to speckles are the most affected by U2AF2 knockdown or RS domain removal. Finally, we show that phosphorylation sites within the U2AF2 RS domain are required for normal splicing, suggesting that its RS domain mediates U2AF2 regulation. Our in-depth bioinformatics analyses reinforce previous observations that alternatively spliced transcripts accumulate in the proximity of speckles. Our results suggest that although U2AF2 is clearly enriched in these regions, its local concentration remains limiting. Consequently, a global reduction in U2AF2 disproportionately affects splicing in the vicinity of nuclear speckles. This provides new insight into how spatial protein availability contributes to the regulation of alternative splicing.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.